Subscribe Become an Author Sign Up Log In

Ben Ramsbottom

Contributor White Papers And Industry Reports

Ben Ramsbottom PhD, is a molecular and cell biologist and CEO at Random42 Over the years, Ben has helped to make Random42 the global leader in medical animation, virtual reality as well as other digital assets for the pharmaceutical industry.

   

Pharmaceutical Marketing Scientific Visualization Virtual Reality

Disclaimer: All opinions, ideas, and thoughts expressed and posted by Contributors at BiopharmaTrend.com platform are their own personal points of view, and do not represent neither Contributor's employers, nor BiopharmaTrend.com.

Posts by this author

Navigating the Challenges of Pharmaceutical Marketing

   2097
Navigating the Challenges of Pharmaceutical Marketing

According to a research report by The Business Research Company, the global pharmaceuticals market was worth $934.8 billion in 2017. This will continue to rise, reaching an incredible $1,170 billion by 2021.

Those who work within the field of pharmaceuticals are well aware of the fragmented and fluctuating nature of the industry. This growing industry is trying to adapt to an ever-changing world in terms of communication, but it is experiencing some roadblocks along the way. We look at some of the most notable challenges facing pharmaceutical marketing today.